Evidence map›Paper›PMID 39962007›Full record

ArticleInsights into imaging2025

A machine learning model based on preoperative multiparametric quantitative DWI can effectively predict the survival and recurrence risk of pancreatic ductal adenocarcinoma.

Chao Qu, Piaoe Zeng, Changlei Li, Weiyu Hu, Dongxia Yang, Hangyan Wang, Huishu Yuan, Jingyu Cao, Dianrong Xiu

Abstract read
In one paragraph

Article in Insights into imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Artificial intelligence in pancreatic cancer: applications in early detection, tumor staging, and survival prediction-a comprehensive review.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chao QuDepartment of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China.
Piaoe ZengDepartment of Radiology, Peking University Third Hospital, Beijing, China.
Changlei LiDepartment of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China.
Weiyu HuDepartment of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China.
Dongxia YangDepartment of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China.
Hangyan WangDepartment of General Surgery, Peking University Third Hospital, Beijing, China.
Huishu YuanDepartment of Radiology, Peking University Third Hospital, Beijing, China.
Jingyu CaoDepartment of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China. cjy7027@163.com.
Dianrong XiuDepartment of General Surgery, Peking University Third Hospital, Beijing, China. xiudianrong@163.com.ORCID http://orcid.org/0009-0000-9497-2182

Funding

Natural Science Foundation of Qingdao Municipality 24-4-4-zrjj-103-jchNatural Science Foundation of Shandong Province ZR2024QH265Taishan Scholar Foundation of Shandong Province Nothe Youth Research Fund of the Affiliated Hospital of Qingdao University QDFYQN2023116
6 · The paper itself

Abstract

purposeTo develop a machine learning (ML) model combining preoperative multiparametric diffusion-weighted imaging (DWI) and clinical features to better predict overall survival (OS) and recurrence-free survival (RFS) following radical surgery for pancreatic ductal adenocarcinoma (PDAC). MATERIALS AND

methodsA retrospective analysis was conducted on 234 PDAC patients who underwent radical resection at two centers. Among 101 ML models tested for predicting postoperative OS and RFS, the best-performing model was identified based on comprehensive evaluation metrics, including C-index, Brier scores, AUC curves, clinical decision curves, and calibration curves. This model's risk stratification capability was further validated using Kaplan-Meier survival analysis.

resultsThe random survival forest model achieved the highest C-index (0.828/0.723 for OS and 0.781/0.747 for RFS in training/validation cohorts). Incorporating nine key factors-D value, T-stage, ADC-value, postoperative 7th day CA19-9 level, AJCC stage, tumor differentiation, type of operation, tumor location, and age-optimized the model's predictive accuracy. The model had integrated Brier score below 0.13 and C/D AUC values above 0.85 for both OS and RFS predictions. It also outperformed traditional models in predictive ability and clinical benefit, as shown by clinical decision curves. Calibration curves confirmed good predictive consistency. Using cut-off scores of 16.73/29.05 for OS/RFS, Kaplan-Meier analysis revealed significant prognostic differences between risk groups (p < 0.0001), highlighting the model's robust risk prediction and stratification capabilities.

conclusionThe random survival forest model, combining DWI and clinical features, accurately predicts survival and recurrence risk after radical resection of PDAC and effectively stratifies risk to guide clinical treatment. CRITICAL RELEVANCE STATEMENT: The construction of 101 ML models based on multiparametric quantitative DWI combined with clinical variables has enhanced the prediction performance for survival and recurrence risks in patients undergoing radical resection for PDAC. KEY POINTS: This study first develops DWI-based radiological-clinical ML models predicting PDAC prognosis. Among 101 models, RFS is the best and outperforms other traditional models. Multiparametric DWI is the key prognostic predictor, with model interpretations through SurvSHAP.

Indexed as

Diffusion-weighted imagingMachine learningPancreatic ductal adenocarcinomaPrediction modelPrognosis

Identifiers

PMID39962007
PMCPMC11833029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.